You can find more information about PF3D7_0918600-RECQ1 using the following links:

Subcellular Localization

• Picture 1
• Picture 2
• Picture 3
• Picture 4
• Picture 5

Affecting Drugs
Drug Name	PubMed Articles (year of publication)
1-aminocyclopropane carboxylic acid	Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry(2018)
2-piperidinecarboxylic acid	Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry(2018)
Aclarubicin	Purification and characterization of a novel 3'-5' DNA helicase from Plasmodium falciparum and its sensitivity to anthracycline antibiotics(2006)
Daunorubicin	Purification and characterization of a novel 3'-5' DNA helicase from Plasmodium falciparum and its sensitivity to anthracycline antibiotics(2006)
Doxorubicin	Purification and characterization of a novel 3'-5' DNA helicase from Plasmodium falciparum and its sensitivity to anthracycline antibiotics(2006) Characterization of recombinant malarial RecQ DNA helicase(2014)
Lepiotin C	Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry(2018)
ML216	Elucidation of DNA Repair Function of PfBlm and Potentiation of Artemisinin Action by a Small-Molecule Inhibitor of RecQ Helicase(2020)
N,N-dipropylsuccinamic acid	Fragment-Based Screening of a Natural Product Library against 62 Potential Malaria Drug Targets Employing Native Mass Spectrometry(2018)
Nogalamycin	Purification and characterization of a novel 3'-5' DNA helicase from Plasmodium falciparum and its sensitivity to anthracycline antibiotics(2006)
Sub2 peptides conjugated to keyhole limpet hemocyanin (klh)	Characterization of recombinant malarial RecQ DNA helicase(2014)